Product Name | MF | CAS | Details |
---|
Penan primary ring intermediate | Details |
sofalcone | C27H30O6 | 64506-49-6 | Details |
Venlafaxine intermediate | Details |
Cilostazol | C20H27N5O2 | 73963-72-1 | Details |
6-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone | Details |
4-nitrobenzyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate | C16H16N2O7 | 74288-40-7 | Details |
Venlafaxine Hydrochloride | C17H28ClNO2 | 99300-78-4 | Details |
Cyclohexanol,1-[2-amino-1-(4-methoxyphenyl)ethyl]-, hydrochloride (1:1) | C15H24ClNO2 | Details |
1-[2-(Dimethylamino)-1-(4-(methoxyphenyl)ethyl)]cyclohexanol hydrochloride | Details |
1-cyclohexanol-4-methoxyphenyl acetonitrile | C15H19NO2 | Details |
Aceclofenac | C16H13Cl2NO4 | 89796-99-6 | Details |
2'-Hydroxycarbonylmethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone | C27H30O6 | Details |
3-[(2S,4S)-4-Mercaptopyrrolidine-2-carboxamido]benzoic acid hydrochloride | C12H15ClN2O3S | 219909-83-8 | Details |
3-[[[(2S,4S)-4-MERCAPTO-2-PYRROLIDINYL-1-(4-NITROBENZYLOXY)CARBONYL]CARBONYL]AMINO]BENZOIC ACID | C20H19N3O7S | 202467-69-4 | Details |
4-(3-methyl-2-butenyloxy)benzaldehyde | C12H14O2 | 28090-12-2 | Details |
Butyldimethylsilyloxyethylcarboxyet | C14H27NO4Si | 90776-58-2 | Details |
4-amino-(1-hydroxybutylidene)-1,1-diphosphonic acid monosodium salt trihydrate | C4H18NNaO10P2 | Details |
4-amino-1-(2-deoxy-indole-erythro-cis-ribofuranosyl)-1,3,5-triazine-2-(hydrogen)-1 | Details |
4-amino-1-D-ribofuranosyl-1,3,5-triazine-2(hydrogen)-1 | Details |
5-(4-Chlorobuty)-1-Cyclohexyl Tetrazol | C11H19ClN4 | 73963-42-5 | Details |
5-Azacytidine | C8H12N4O5 | 320-67-2 | Details |
5-bromo-2-(trifluoromethyl) pyridine | C6H3BrF3N | 436799-32-5 | Details |
6-methyl-erythromycin | Details |
6-hydroxy-3,4-dihydro-quinolin-2-one | C9H9NO2 | Details |
8-Bromooctanoic acid ethyl ester | C10H19BrO2 | 29823-21-0 | Details |
N,N-Dimethylallylamine | C5H11N | 2155-94-4 | Details |
Dimethyl phthalate | C10H10O4 | 131-11-3 | Details |
EMBA | C17H22O5 | Details |
3-Methyl(E)-7-[3-(4-fluorophenyl)-1-methylethyl-indol-2-yl]-3-hydroxy-5-oxohept-6-enoate | C25H26FNO4 | 93957-52-9 | Details |
Ammonium dihydrogen phosphate | H6NO4P | 7722-76-1 | Details |
MBBA | C18H21NO | 26227-73-6 | Details |
Methyl 4-methylbenzoate | C9H10O2 | 99-75-2 | Details |
beta-Methyl vinyl phosphate (MAP) | C29H27N2O10P | 90776-59-3 | Details |
N,N-Dimethylacrylamide | C5H9NO | 2680-03-7 | Details |
Alendronate sodium | C4H13NNaO7P2 | 129318-43-0 | Details |
Biapenem | C15H18N4O4S | 120410-24-4 | Details |
6,7-dihydro-6-mercapto-5h-pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride | C5H8ClN3S | 153851-71-9 | Details |
5-Aza-2'-deoxycytidine | C8H12N4O4 | 2353-33-5 | Details |
FLUVASTATIN SODIUM | C24H25FNNaO4 | 93957-55-2 | Details |
Fluvastatin sodium intermediate | Details |
Intermediate of Fluvastatin | C28H34FNO4 | 194934-96-8 | Details |
Erythromycin oxime | C37H67NO13 | 114-07-8 | Details |
Imazamox intermediate | Details |
Clarithromycin | C38H69NO13 | 81103-11-9 | Details |
Intermediate clarithromycin | Details |
4-Nitrobenzyl chloroformate | C8H6ClNO4 | 4457-32-3 | Details |
Meropenem | C17H25N3O5S | 96036-03-2 | Details |
2S CIS PNB(SIDE CHAIN) | C15H19N3O5S | 96034-64-9 | Details |
3-(2-Bromo-1-oxopropyl)-spiro[2H-1,3-benzoxazine-2,1'-cyclohexan]-4(3H)-one | C16H18BrNO3 | 158299-05-9 | Details |
Meropenem side chain | Details |
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)quinolinone | C20H27N5O2 | Details |
6,7-Dihydro-6-mercapto-5H-pyrazolo[1,2-A][1,2,4]triazole chloride | C5H8ClN3S | Details |
Product Total: Product Page: | ||||
1 |